NIIN Output Data
NIIN:
NSN:
Item Name:
INSULIN HUMAN ZINC SUSPENSION , US
Definition:
Reference/Part Number
| Part Number | CAGE | Status | RNCC | RNVC | DAC | RNAAC | MSDS | SADC |
|---|---|---|---|---|---|---|---|---|
| NDC00003-1835-10 | 60554 | A | 5 | 9 | 4 | KX | ||
| NOVOLIN-L | 60554 | A | 5 | 1 | 4 | KX | ||
| NDC00169-1835-11 | 60554 | A | 3 | 2 | 4 | KX |
CAGE Information
| Code | Company |
|---|---|
| 60554 | NOVO NORDISK INC. |
Federal Supply Class
Title
DRUGS AND BIOLOGICALS
Inclusions:
INCLUDES ALL DRUGS, MEDICINAL GRADE CHEMICALS, AND BIOLOGICALS SUBJECT TO THE FEDERAL FOOD, DRUG AND COSMETIC ACT, LISTED IN THE MONOGRAPH SECTION OF THE U.S. PHARMACOPEIA OR THE NATIONAL FORMULARY OR COVERED BY THE UNITED STATES ADOPTED NAMES (USAN). OTHER NATIONS MAY APPLY THEIR OWN LEGAL DOCUMENTS.
Exclusions:
EXCLUDES MEDICATED COSMETICS AND TOILETRIES CLASSIFIABLE IN FSC 6508 AND IN VITRO DIAGNOSTIC SUBSTANCES AND REAGENTS CLASSIFIABLE IN FSC 6550, AND VETERINARY DRUGS AND BIOLOGICALS CLASSIFIABLE IN FSC 6509.
Characteristics (Decoded)
| MRC | Requirements Statement | Clear Text Reply |
|---|---|---|
| CXCY | PART NAME ASSIGNED BY CONTROLLING AGENCY | INSULIN HUMAN ZINC SUSPENSION USP 100UN/ML 10ML MULTI DOSE VIAL |
| THPE | THERAPEUTIC EQUIVALENT | NOVOLIN BY NOVO NORDISK |
| CRLK | PRIMARY CONTAINER CONTENT QUANTITY | 10.000 MILLILITERS |
| AKJA | ACTIVE MEDICAMENT MEDICINAL STRENGTH | 100.000 USP UNITS INSULIN PER MILLILITER |
| FEAT | SPECIAL FEATURES | RECOMBINANT DNA ORIGIN (YEAST) |
| CQCT | PRIMARY CONTAINER TYPE | VIAL, MULTIPLE DOSE |